{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T21:36:49Z","timestamp":1775511409536,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":562,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Results in Immunology"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1016\/j.rinim.2012.01.001","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T19:07:08Z","timestamp":1326136028000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL"],"prefix":"10.1016","volume":"2","author":[{"given":"Roland","family":"Fiskesund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Bulatovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Vikstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"de Faire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Frosteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rinim.2012.01.001_bib1","doi-asserted-by":"crossref","unstructured":"Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 473:317\u201325.","DOI":"10.1038\/nature10146"},{"key":"10.1016\/j.rinim.2012.01.001_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frostegard","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rinim.2012.01.001_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-008-8095-9","article-title":"Oxidative modification of LDL: its pathological role in atherosclerosis","volume":"37","author":"Itabe","year":"2009","journal-title":"Clinical Reviews in Allergy & Immunology"},{"key":"10.1016\/j.rinim.2012.01.001_bib4","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0021-9150(97)00305-5","article-title":"Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis","volume":"137","author":"Holvoet","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rinim.2012.01.001_bib5","doi-asserted-by":"crossref","unstructured":"Hjerpe C, Johansson D, Hermansson A, Hansson GK, Zhou XH. Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-\/-) mice. Atherosclerosis 209:436\u201341.","DOI":"10.1016\/j.atherosclerosis.2009.10.003"},{"key":"10.1016\/j.rinim.2012.01.001_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.RES.85.4.311","article-title":"Evidence that phospholipid oxidation products and\/or platelet-activating factor play an important role in early atherogenesis\u2014in vitro and in vivo inhibition by WEB 2086","volume":"85","author":"Subbanagounder","year":"1999","journal-title":"Circulation Research"},{"key":"10.1016\/j.rinim.2012.01.001_bib7","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.2174\/092986707782793899","article-title":"Role of lysophosphatidylcholine (LPC) in atherosclerosis","volume":"14","author":"Matsumoto","year":"2007","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.rinim.2012.01.001_bib8","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0891-5849(00)00234-3","article-title":"Bioactive phospholipid oxidation products","volume":"28","author":"Marathe","year":"2000","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/j.rinim.2012.01.001_bib9","doi-asserted-by":"crossref","unstructured":"Choi J, Zhang WJ, Gu XD, Chen X, Hong L, Laird JM, et al. Lysophosphatidylcholine is generated by spontaneous deacylation of oxidized phospholipids. Chemical Research in Toxicology 24:111\u20138.","DOI":"10.1021\/tx100305b"},{"key":"10.1016\/j.rinim.2012.01.001_bib10","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI8472","article-title":"Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity","volume":"105","author":"Shaw","year":"2000","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.rinim.2012.01.001_bib11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1050-1738(01)00098-6","article-title":"Evidence for a role of phospholipid oxidation products in atherogenesis","volume":"11","author":"Berliner","year":"2001","journal-title":"Trends in Cardiovascular Medicine"},{"key":"10.1016\/j.rinim.2012.01.001_bib12","series-title":"The Vulnerable Atherosclerotic Plaque: Strategies for Diagnosis and Management","author":"Renu Virmani","year":"2006"},{"key":"10.1016\/j.rinim.2012.01.001_bib13","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.4049\/jimmunol.0804191","article-title":"IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells","volume":"182","author":"Chen","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.rinim.2012.01.001_bib14","doi-asserted-by":"crossref","unstructured":"de Faire U, Su J, Hua X, Frostegard A, Halldin M, Hellenius ML, et al.. Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism. Journal of Autoimmunity 34:73\u20139.","DOI":"10.1016\/j.jaut.2009.05.003"},{"key":"10.1016\/j.rinim.2012.01.001_bib15","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1172\/JCI36800","article-title":"Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans","volume":"119","author":"Chou","year":"2009","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.rinim.2012.01.001_bib16","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","article-title":"Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL","volume":"9","author":"Binder","year":"2003","journal-title":"Nature Medicine"},{"key":"10.1016\/j.rinim.2012.01.001_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2005.11.033","article-title":"Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice","volume":"189","author":"Faria-Neto","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rinim.2012.01.001_bib18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jacc.2006.11.054","article-title":"Phosphorylcholine-targeting immunization reduces atherosclerosis","volume":"50","author":"Caligiuri","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.rinim.2012.01.001_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00195251","article-title":"Phosphorylcholine antibodies in pulmonary infection","volume":"179","author":"Nishinarita","year":"1990","journal-title":"Medical Microbiology and Immunology"},{"key":"10.1016\/j.rinim.2012.01.001_bib20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.4049\/jimmunol.132.3.1323","article-title":"Subpopulations of antibodies to phosphocholine in human serum","volume":"132","author":"Brown","year":"1984","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.rinim.2012.01.001_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2005.10.017","article-title":"Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension","volume":"188","author":"Su","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rinim.2012.01.001_bib22","doi-asserted-by":"crossref","unstructured":"Fiskesund R., Stegmayr B., Hallmans G., Vikstrom M., Weinehall L., de Faire U., et al. Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden. Stroke 41:607\u201312.","DOI":"10.1161\/STROKEAHA.109.558742"},{"key":"10.1016\/j.rinim.2012.01.001_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/HJR.0b013e32832a05df","article-title":"Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden","volume":"16","author":"Gronlund","year":"2009","journal-title":"European Journal of Cardiovascular Prevention and Rehabilitation"},{"key":"10.1016\/j.rinim.2012.01.001_bib24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.atherosclerosis.2008.07.009","article-title":"Low levels of IgM antibodies against phosphorylcholine\u2014a potential risk marker for ischemic stroke in men","volume":"203","author":"Sjoberg","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rinim.2012.01.001_bib25","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/01.CIR.0000039288.86470.DD","article-title":"Calcium antagonist, lacidipine slows down progression of asymptomatic carotid atherosclerosis\u2014principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial","volume":"106","author":"Zanchetti","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.rinim.2012.01.001_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/01.HYP.33.1.53","article-title":"Autoantibodies to OxLDL are decreased in individuals with borderline hypertension","volume":"33","author":"Wu","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.rinim.2012.01.001_bib27","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/bi00784a024","article-title":"Specificity for phosphorylcholine of six murine myeloma proteins reactive with pneumococcus C-polysaccharide and beta-lipoprotein","volume":"10","author":"Leon","year":"1971","journal-title":"Biochemistry"},{"key":"10.1016\/j.rinim.2012.01.001_bib28","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1073\/pnas.110039497","article-title":"Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse","volume":"97","author":"Mi","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.rinim.2012.01.001_bib29","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1194\/jlr.R500005-JLR200","article-title":"The role of natural antibodies in atherogenesis","volume":"46","author":"Binder","year":"2005","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.rinim.2012.01.001_bib30","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/rheumatology\/ken120","article-title":"Natural antibodies against phosphorylcholine as potential protective factors in SLE","volume":"47","author":"Su","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rinim.2012.01.001_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2796.2008.01968.x","article-title":"Oxidation-specific epitopes are important targets of innate immunity","volume":"263","author":"Chou","year":"2008","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.rinim.2012.01.001_bib32","first-page":"197","article-title":"Periodontal diseases and cardiovascular events: meta-analysis of observational studies","volume":"59","author":"Blaizot","year":"2009","journal-title":"International Dental Journal"},{"key":"10.1016\/j.rinim.2012.01.001_bib33","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/IAI.67.9.4814-4818.1999","article-title":"Antiphosphorylcholine antibody levels are elevated in humans with periodontal diseases","volume":"67","author":"Schenkein","year":"1999","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.rinim.2012.01.001_bib34","first-page":"241","article-title":"Human-IgG subclassers and their relation to carbohydrate antigen immunocompetence","volume":"5","author":"Scott","year":"1988","journal-title":"Diagnostic and Clinical Immunology"},{"key":"10.1016\/j.rinim.2012.01.001_bib35","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/424517","article-title":"Cross-reactivity of human immunoglobulin G2 recognizing phosphorylcholine and evidence for protection against major bacterial pathogens of the human respiratory tract","volume":"190","author":"Goldenberg","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl:S382-7","key":"10.1016\/j.rinim.2012.01.001_bib36","article-title":"Mechanisms and consequences of macrophage apoptosis in atherosclerosis","volume":"50","author":"Seimon","year":"2009","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.rinim.2012.01.001_bib37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0022-2275(20)42662-8","article-title":"Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis","volume":"10","author":"Portman","year":"1969","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.rinim.2012.01.001_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2004.06.011","article-title":"Levels of natural IgM antibodies against phosphorylcholine in healthy individuals and in patients undergoing isolated limb perfusion","volume":"293","author":"Padilla","year":"2004","journal-title":"Journal of Immunological Methods"}],"container-title":["Results in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211283912000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211283912000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T07:15:50Z","timestamp":1686640550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211283912000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":38,"alternative-id":["S2211283912000020"],"URL":"https:\/\/doi.org\/10.1016\/j.rinim.2012.01.001","relation":{},"ISSN":["2211-2839"],"issn-type":[{"value":"2211-2839","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL","name":"articletitle","label":"Article Title"},{"value":"Results in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rinim.2012.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}